Organization
University of Munich
4 abstracts
Abstract
Multimodal artificial intelligence models from baseline histopathology to predict prognosis in HR+ HER2- early breast cancer: Subgroup analysis.Org: University Hospital LMU Munich, Medical School Hannover, West German Study Group, Breast Unit, Charité-Universitätsmedizin Berlin,
Abstract
Artificial intelligence and identifying prognostic patterns in upper tract urothelical carcinoma (UTUC).Org: University of Munich, Munich, Germany, Germany,
Abstract
Patient priorities and expectations of systemic therapy in metastatic renal cell carcinoma.Org: KCCure, University of Michigan, University of Texas MD Anderson Cancer Center, City of Hope National Medical Center, University of Texas Southwestern Medical Center,
Abstract
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.Org: Bayer AG, Charité - Universitätsmedizin Berlin, Berlin, Germany, University of Munich, University of Pisa & Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Germany,